Founded Year
1988Stage
PIPE | IPOMarket Cap
0.01BGeoVax Patents
GeoVax has filed 12 patents.
The 3 most popular patent topics include:
- Vaccines
- Animal viral diseases
- Immunology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/18/2018 | 4/26/2022 | Plasmodium, Vaccines, Malaria, Transcription factors, Animal viral diseases | Grant |
Application Date | 9/18/2018 |
|---|---|
Grant Date | 4/26/2022 |
Title | |
Related Topics | Plasmodium, Vaccines, Malaria, Transcription factors, Animal viral diseases |
Status | Grant |
Latest GeoVax News
May 5, 2022
Healio Interview Disclosures: Diamond reports a consulting role with GeoVax Labs, Inc. GeoVax Labs, Inc. has licensed COH04S1, and the accompanied platform that is used, as the exclusive licensee. City of Hope receives upfront payments, royalties and funding through clinical trial agreements. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Please try again later. If you continue to have this issue please contact customerservice@slackinc.com . Back to Healio An investigational COVID-19 vaccine developed by City of Hope induced a robust immune response against SARS-CoV-2, according to results of a phase 1 clinical trial. In addition, researchers observed no significant adverse events. The findings — published in The Lancet Microbe — support advancing the vaccine into phase 2 testing specifically for immunocompromised individuals with cancer, according to investigators. Healio spoke with lead vaccine developer Don Diamond, PhD, about the efficacy and safety observed so far, the next steps in research, and the potential benefits this vaccine could provide to patients with cancer. Reference:
GeoVax Web Traffic
GeoVax Rank
When was GeoVax founded?
GeoVax was founded in 1988.
Where is GeoVax's headquarters?
GeoVax's headquarters is located at 1900 Lake Park Drive, Smyrna.
What is GeoVax's latest funding round?
GeoVax's latest funding round is PIPE.
Who are the investors of GeoVax?
Investors of GeoVax include Armistice Capital, Emory University and Emtech Bio.
Who are GeoVax's competitors?
Competitors of GeoVax include Merus, CoImmune, Humanetics Corporation, Profectus BioSciences, Tobira Therapeutics and 12 more.
You May Also Like
Panacos is developing anti-infective products through discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Per the company, Panacos' proprietary discovery technologies are designed to combat resistance by focusing on novel targets in the virus life cycle, including virus maturation and virus fusion.
Profectus Biosciences is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases. The Company's name, Profectus, when translated from its Latin roots, means"to advance or improve". The Company's proof of concept target is human immunodeficiency virus (HIV) with an intermediate term focus on hepatitis C virus (HCV).
Photopharmica, developing light sensitive drugs for the prevention and treatment of diseases in the anti-infective and oncology markets photosensitisers, for industrial applications
Opal Therapeutics is an immunotherapy company focused on therapies for human immunodeficiency virus (HIV) and Hepatitis C (HCV), based on technology from the University of Melbourne.
Koronis Pharma develops antiviral therapeutics based on Viral Decay Acceleration, which exploits the strength of a virus to target its collapse.
CoImmune, fka Argos Therapeutics, is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases. Using biological components from each patient, the company's immunotherapies employ the patient's dendritic cells to activate an immune response specific to the patient's disease.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.